Kimya & İlaç — Singapur Borsası Sektör Analizi

Total Market Cap 12.8B

P/E (Weighted)Price to Earnings ratio. 3.20 Medyan: 2.45

P/B (Weighted)Price to Book ratio. 2.22 Medyan: 0.72

P/E (Arithmetic)Simple average P/E. 2.45

Avg Lothien ScoreFinancial health score (0-100). 72

Avg DamodaranDamodaran scoring model. 63

Avg PotentialExpected upside potential %. +77.6%

Avg Dalio ScoreDalio debt cycle score. 70

Distributions

Lothien Distribution

0–25

25–40

40–55

55–70

70–100

Damodaran Distribution

0–25

25–40

40–55

55–70

70–100

Upside Potential

-100% – -20%

-20% – +0%

+0% – +20%

+20% – +50%

+50%+

Stocks in Sector

Stock	PriceCurrent trading price.	Market CapTotal market capitalization.	FKPrice to Earnings ratio.	PD/DDPrice to Book ratio.	EV/EBITDAEnterprise Value / EBITDA.	ROICReturn on Invested Capital.	WACCWeighted Average Cost of Capital (WACC).	PUSLAFinancial health score (0-100).	DamodaranValuation score.	Intrinsic ValueFair value via DCF model.	Potential %Expected upside potential %.	Dalio RiskDalio Debt Cycle Score	Debt/EquityDebt to Equity ratio.
QES	0.66	629.2M	0.38	0.73	—	8.6%	13.2%	82	66	1.85	+133.3%	70	0.00
E5H	0.32	4.1B	2.49	0.59	1.34	9.8%	7.7%	80	65	0.67	+81.2%	69	0.51
Y35	0.02	84.7M	1.53	0.58	0.47	—	—	79	62	0.06	+150.0%	91	0.56
BNE	0.55	156.4M	1.91	1.99	1.11	24.9%	8.9%	76	81	1.09	+76.2%	64	1.82
T12	0.95	149.3M	2.40	0.71	1.24	6.9%	10.6%	75	61	1.97	+80.0%	82	0.28
MV4	0.28	420.2M	3.78	0.37	2.03	5.9%	7.2%	69	60	0.56	+75.0%	63	0.72
A30	0.16	350.1M	2.85	1.10	3.87	6.0%	6.2%	63	58	0.24	+39.2%	47	3.64
EB5	4.47	6.9B	3.92	3.54	2.69	22.6%	9.9%	50	52	3.62	-14.1%	72	0.45